Detalhe da pesquisa
1.
Non-mutagenic impurities - Recent industry experience of using dose durational limits in drug development.
Regul Toxicol Pharmacol
; 147: 105559, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145838
2.
Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice.
Regul Toxicol Pharmacol
; 126: 105029, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455009
3.
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer.
Oncol Ther
; 11(1): 111-128, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645622